News | March 2024

dQ&A at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

SAN FRANCISCO, March 7, 2024 – dQ&A, the leading diabetes research company, today announced that it will present a total of three abstracts at this year’s Advanced Technologies & Treatments for Diabetes Conference, in Florence, Italy, March 6-9. The company will share their latest groundbreaking research, including an oral presentation exploring the value of smartwatches in continuous glucose monitoring.

dQ&A works with over 70 industry leaders in insulin, injectables, orals, CGM, BGM, insulin pumps, and AID systems. They are internationally recognized for their deep expertise in diabetes-focused research and consulting across Europe, the United States, and Canada.

Abstracts presented at ATTD are:

  • Benefits of viewing continuous glucose monitoring data on a smartwatch among people with diabetes in Europe.  (including oral discussion)
  • Understanding willingness to prescribe automated insulin delivery systems among primary care physicians
  • Evaluating the perceived benefit of social media usage among diabetes technology users and non-users

“The new set of research we are presenting at ATTD highlights dQ&A’s commitment to driving diabetes innovation forward, as we further explore the important role new technologies can play in improving the lives of people with diabetes,” said Richard Wood, CEO, dQ&A. “I am proud of the depth of insights and quality of data these three abstracts bring forth, and that we are able to share our specialized diabetes expertise with the international diabetes community to further the cause.”

For more information and to receive a copy of the data presented, send us an email at


About dQ&A

For those who drive critical diabetes research decisions in their organization, dQ&A is an ally for unparalleled insights and expertise.  With decades of experience in classic and cutting-edge research techniques, we are a diabetes insights partner that knows what it takes to get the right answers. Our exclusive panels in the United States, Canada, and Europe deliver authentic and hard-to-find participants.  This work is our focus and passion. Partner with a team that truly gets it: your business, product, prescribers, and your end customer. To learn more, visit